Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Submitted by
admin
on November 30, 2016 - 9:44pm
Source:
Yahoo/Reuters
News Tags:
Pfizer
biosimilars
Herceptin
PF-05280014
HER2-positive metastatic breast cancer
Headline:
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Do Not Allow Advertisers to Use My Personal information
